EUVIMEDEUVIMED entdecken
Crossref

0550 Risk of alopecia areata among rheumatoid arthritis and psoriasis patients treated with TNF inhibitors

D.A. Ramos-Briceño, J.H. Park, D. Garate, N. Swamy, A. Munoz Gonzalez

Journal of Investigative Dermatology · 2026-08 · 146 (8) · S95

DOI: 10.1016/j.jid.2026.06.581 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2026-08. Verfasst von D.A. Ramos-Briceño und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Ramos-Briceño, D., Park, J., Garate, D., Swamy, N., & Gonzalez, A. M. (2026). 0550 Risk of alopecia areata among rheumatoid arthritis and psoriasis patients treated with TNF inhibitors. Journal of Investigative Dermatology, 146(8), S95. https://doi.org/10.1016/j.jid.2026.06.581

Vancouver

Ramos-Briceño D, Park J, Garate D, Swamy N, Gonzalez AM. 0550 Risk of alopecia areata among rheumatoid arthritis and psoriasis patients treated with TNF inhibitors. Journal of Investigative Dermatology. 2026;146(8):S95. doi:10.1016/j.jid.2026.06.581

BibTeX
@article{RamosBriceo2026,
  author = {Ramos-Briceño, D.A. and Park, J.H. and Garate, D. and Swamy, N. and Gonzalez, A. Munoz},
  title = {0550 Risk of alopecia areata among rheumatoid arthritis and psoriasis patients treated with TNF inhibitors},
  journal = {Journal of Investigative Dermatology},
  year = {2026},
  volume = {146},
  number = {8},
  pages = {S95},
  doi = {10.1016/j.jid.2026.06.581}
}
Kostenlos starten →